SCHEMBL8010609

SCHEMBL8010609

[CH2]c1ccc(N(C)C(=O)CCCCCc2ccccc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 6/20 0.60
MAPT P10636 2/20 0.51
RXFP1 Q9HBX9 1/20 0.51
KDM4A O75164 1/20 0.51
KDM5A P29375 1/20 0.51
KDM4C Q9H3R0 1/20 0.51
PHF8 Q9UPP1 1/20 0.51
KDM2A Q9Y2K7 1/20 0.51
MLYCD O95822 1/20 0.51
HDAC1 Q13547 1/20 0.47
HDAC2 Q92769 1/20 0.47
SIGMAR1 Q99720 2/20 0.46
FAAH O00519 3/20 0.46
CES1 P23141 3/20 0.46
NPC1 O15118 1/20 0.45
ALDH1A1 P00352 1/20 0.45
ALOX15 P16050 1/20 0.45
NFKB1 P19838 1/20 0.45
MAPK1 P28482 1/20 0.45
RAB9A P51151 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8695755 0.86 ALOX5 (0.63) ALOX5MAPTRXFP1KDM4AKDM5A
SCHEMBL8000964 0.83 ALOX5 (0.60) ALOX5MAPTRXFP1KDM4AKDM5A
SCHEMBL2201276 0.83 ALOX5 (0.60) ALOX5MAPTRXFP1KDM4AKDM5A
SCHEMBL2200556 0.82 ALOX5 (0.61) ALOX5MAPTRXFP1KDM4AKDM5A
SCHEMBL8696461 0.81 ALOX5 (0.56) ALOX5MAPTMLYCDHDAC1HDAC2
SCHEMBL17064249 0.80 ALOX5 (0.55) ALOX5MAPTMLYCDHDAC1HDAC2
SCHEMBL16658769 0.79 ALOX5 (0.75) ALOX5MAPTRXFP1KDM4AKDM5A
SCHEMBL16658765 0.79 ALOX5 (0.75) ALOX5MAPTRXFP1KDM4AKDM5A
SCHEMBL16658768 0.79 ALOX5 (0.75) ALOX5MAPTRXFP1KDM4AKDM5A
SCHEMBL16658770 0.79 ALOX5 (0.75) ALOX5MAPTRXFP1KDM4AKDM5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1060173-C Heterocyclic compound with activity against diabetes and preparation and application of same MITSUTAKA CO LTD (JP) 2001-01-03 CN disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
CN-1157288-A Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1997-08-20 CN disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
CN-1118781-A Heterocyclic compound with activity against diabetes and preparation and application of same MITSUTAKA CO LTD (JP) 1996-03-20 CN disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed